NCT02730468View on ClinicalTrials.gov

SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay

CompletedOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

October 31, 2017

Conditions
Sepsis
Trial Locations (1)

94305

Stanford University Hospital, Stanford

All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Karius, Inc.

INDUSTRY

NCT02730468 - SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay | Biotech Hunter | Biotech Hunter